IGHE and congenital rubella syndrome: Initial reactions presented with three patterns as: type I (IgE or non–IgE‐mediated mast cell degranulation, n: 20/45, 44.4%), CRS (n: 12/45, 26.7%), and mixed reactions (n: 13/45, 28.8%) in our study.